Association Between Twelve Polymorphisms in Five X-ray Repair Cross-complementing Genes and the Risk of Urological Neoplasms: A Systematic Review and Meta-Analysis.
Polymorphisms in X-ray repair cross-complementing (XRCC) genes have been implicated in altering the risk of various urological cancers. However, the results of reported studies are controversial. To ascertain whether polymorphisms in XRCC genes are associated with the risk of urological neoplasms, we conducted present updated meta-analysis and systematic review. Summary odds ratios (ORs) and corresponding 95% confidence intervals (CIs) were used to estimate the association. Finally, 54 publications comprising 129 case-control studies for twelve polymorphisms in five XRCC genes were enrolled. We identified that XRCC1-rs25489 polymorphism was associated with an increased risk of urological neoplasms in heterozygote and dominant models. Moreover, in the subgroup analysis by cancer type, we found that XRCC1-rs25489 polymorphism was associated with an increased risk of bladder cancer (BC) in heterozygote model. Although overall analyses suggested a null result for XRCC1-rs25487 polymorphism, in the stratified analysis by ethnicity, an increased risk of urological neoplasms for Asians in allelic and homozygote models was identified. While for other polymorphisms in XRCC genes, no significant association was uncovered. To sum up, our results indicated that XRCC1-rs25489 polymorphism is a risk factor for urological neoplasms, particularly for BC. Further studies with large sample size are needed to validate these findings.
Department of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei, China; Institute of Urology, Anhui Medical University, Hefei, China; Graduate School of Anhui Medical University, Hefei, China.
Meng
M
Zhang
Department of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei, China; Institute of Urology, Anhui Medical University, Hefei, China; Graduate School of Anhui Medical University, Hefei, China.
Wanzhen
W
Li
Department of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei, China; Institute of Urology, Anhui Medical University, Hefei, China; Graduate School of Anhui Medical University, Hefei, China.
Zongyao
Z
Hao
Department of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei, China; Institute of Urology, Anhui Medical University, Hefei, China; Graduate School of Anhui Medical University, Hefei, China.
Jun
J
Zhou
Department of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei, China; Institute of Urology, Anhui Medical University, Hefei, China; Graduate School of Anhui Medical University, Hefei, China. Electronic address: lzhang@ahmu.edu.cn.
Li
L
Zhang
Department of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei, China; Institute of Urology, Anhui Medical University, Hefei, China; Graduate School of Anhui Medical University, Hefei, China. Electronic address: liang_chaozhao@ahmu.edu.cn.
Chaozhao
C
Liang
D044466:Asian People / Q000235:genetics; D016022:Case-Control Studies; D016208:Databases, Factual; D006579:Heterozygote; D006720:Homozygote; D006801:Humans; D016017:Odds Ratio; D020641:Polymorphism, Single Nucleotide; D012307:Risk Factors; D014571:Urologic Neoplasms / Q000378:metabolism / Q000473:pathology*; D000076105:X-ray Repair Cross Complementing Protein 1 / Q000235:genetics*
D000076105:X-ray Repair Cross Complementing Protein 1; C000619371:XRCC1 protein, human
Meta-analysis; Polymorphism; Risk; Urological neoplasm; XRCC